Policy & Regulation

Critical Path Initiative at the FDA

Read more

Breakthrough for cannabis medicines

Read more

The road to healthcare reform in the US

Read more

Regulators to make more information public

Read more

US healthcare reform: where things stand

Read more

Unwinding the mystery behind TGN1412 -- New preclinical tests for immunology drugs

Read more

EMEA explains new certification scheme

Read more

Public health funding opportunities from the US

Read more

Setting regulatory standards for advanced therapies

Read more

Preparing for the advanced therapy Regulation

Read more